Biogaia AB
Records under this name other than the patents Biogaia AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,968,643 | Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,232,001 | Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,374,924 | Use of selected lactic acid bacteria for reducing infantile colic Term ended Term ended Jun 5, 2026 · From the USPTO record | Term ended | Term ended Jun 5, 2026 | From the USPTO record |
| US 8,343,483 | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries Term ended Term ended Dec 29, 2025 · From the USPTO record | Term ended | Term ended Dec 29, 2025 | From the USPTO record |
| US 7,344,867 | Selection and use of lactic acid bacteria for reducing inflammation in mammals Term ended Term ended Apr 15, 2025 · From the USPTO record | Term ended | Term ended Apr 15, 2025 | From the USPTO record |
| US 9,555,065 | Method for selection of agents influencing intestinal motility disorders and pain Lapsed on the fee record Ended Jan 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 31, 2025 | From the USPTO record |
| US 8,114,397 | Stabilized bacterial formulation Lapsed on the fee record Ended Feb 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 14, 2024 | From the USPTO record |
| US 7,105,336 | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter Term ended Term ended Nov 25, 2023 · From the USPTO record | Term ended | Term ended Nov 25, 2023 | From the USPTO record |
| US 6,872,565 | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries Term ended Term ended Apr 27, 2023 · From the USPTO record | Term ended | Term ended Apr 27, 2023 | From the USPTO record |
| US 8,945,534 | Controlled activation of the reuterin-production machinery of Lactobacillus Lapsed on the fee record Ended Feb 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2023 | From the USPTO record |